Nab-paclitaxel Combined with Bevacizumab in the Treatment of Metastatic Extrapulmonary Neuroendocrine Carcinoma

NCT04705519 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

79

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine Carcinoma

Interventions

DRUG: Nab-paclitaxel Combined With Bevacizumab

Sponsor

Peking University

Collaborators

[object Object]